Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sanders

Showing results (801-810 of 915) with videos related to

Pageof 92
Sort By:
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Journal of Virology|June 2, 2021
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope GlycoproteinM M van Haaren, L E McCoy, J L Torres, et al.
Cell Reports. Medicine|May 18, 2022
Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibodyBehnaz Heydarchi, Danielle S Fong, Hongmei Gao, et al.
Journal of Plankton Research|July 24, 2023
Mixoplankton and mixotrophy: future research prioritiesNicole C Millette, Rebecca J Gast, Jessica Y Luo, et al.
Cell Reports|March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralizationChloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Pathogens & Immunity|June 17, 2021
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in SalivaThomas J Ketas, Devidas Chaturbhuj, Victor M Cruz Portillo, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
Nature Communications|November 26, 2022
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidateKwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Plos Pathogens|June 16, 2017
Three mutations switch H7N9 influenza to human-type receptor specificityRobert P de Vries, Wenjie Peng, Oliver C Grant, et al.
NPJ Vaccines|March 30, 2025
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaquesHélène Letscher, Delphine Guilligay, Gregory Effantin, et al.
Pageof 92

Showing results (801-810 of 915) with videos related to

Sort By:
Pageof 92
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Journal of Virology|June 2, 2021
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope GlycoproteinM M van Haaren, L E McCoy, J L Torres, et al.
Cell Reports. Medicine|May 18, 2022
Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibodyBehnaz Heydarchi, Danielle S Fong, Hongmei Gao, et al.
Journal of Plankton Research|July 24, 2023
Mixoplankton and mixotrophy: future research prioritiesNicole C Millette, Rebecca J Gast, Jessica Y Luo, et al.
Cell Reports|March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralizationChloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Pathogens & Immunity|June 17, 2021
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in SalivaThomas J Ketas, Devidas Chaturbhuj, Victor M Cruz Portillo, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
Nature Communications|November 26, 2022
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidateKwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Plos Pathogens|June 16, 2017
Three mutations switch H7N9 influenza to human-type receptor specificityRobert P de Vries, Wenjie Peng, Oliver C Grant, et al.
NPJ Vaccines|March 30, 2025
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaquesHélène Letscher, Delphine Guilligay, Gregory Effantin, et al.
Pageof 92